PCV48 MEDICATION USE AND ASSOCIATED ANNUAL COSTS IN PATIENTS AT RISK OF ATHEROTHROMBOSIS- RESULTS FOR GERMANY, SPAIN AND THE UK FROM THE REDUCTION OF ATHEROTHROMBOSIS FOR CONTINUED HEALTH (REACH) REGISTRY
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63664-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)63664-9/fulltext
Title :
PCV48 MEDICATION USE AND ASSOCIATED ANNUAL COSTS IN PATIENTS AT RISK OF ATHEROTHROMBOSIS- RESULTS FOR GERMANY, SPAIN AND THE UK FROM THE REDUCTION OF ATHEROTHROMBOSIS FOR CONTINUED HEALTH (REACH) REGISTRY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63664-9&doi=10.1016/S1098-3015(10)63664-9
First page :
Section Title :
Open access? :
No
Section Order :
515